Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Equipment & Ancillary Solutions Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering.
The clinical trial equipment and ancillary solutions market is transforming rapidly as organizations adapt to digitalization, diverse trial models, and evolving compliance requirements. Strategic decision-makers require up-to-date insight into technological integration, procurement resilience, and regulatory shifts impacting operational performance and growth.
Market Snapshot: Clinical Trial Equipment & Ancillary Solutions Market
The Clinical Trial Equipment & Ancillary Solutions Market grew from USD 5.00 billion in 2025 to USD 5.46 billion in 2026. It is expected to continue growing at a CAGR of 10.05%, reaching USD 9.78 billion by 2032. This growth reflects the convergence of technology platforms, the evolution of decentralized and hybrid trial models, and a renewed focus on resilient, patient-centric operations across global clinical development.
Scope & Segmentation
This report covers the full spectrum of the clinical trial equipment and ancillary solutions market, framing drivers and barriers shaping organizational strategy.
- Component Categories: Distinguishes between ancillary solutions-including laboratory services, patient engagement, and digital management systems-and physical equipment such as imaging devices, drug dispensing units, and monitoring tools.
- Development Phases: Maps how early-phase, adaptive, and late-stage trials define procurement and deployment approaches for monitoring, data integration, and logistics platforms.
- Therapeutic Areas: Addresses unique demands across cardiology, neurology, oncology, immunology, and infectious disease trials, highlighting technology needs and workflow differentiation.
- End-User Types: Refines analysis for academic/research institutions, biotechnology firms, contract research organizations, medical device companies, and pharmaceutical manufacturers.
- Regional Coverage: Evaluates mature and emerging regulatory and operational contexts across the Americas, Europe, Middle East, Africa, and Asia-Pacific, emphasizing clinical infrastructure, supply chain dynamics, and manufacturing diversity.
- Technology Trends: Explores platforms for electronic data capture, remote monitoring, advanced analytics, and patient-centric engagement integrated with robust supply-chain and validation processes.
Key Takeaways for Senior Decision-Makers
- Integrated digital platforms and interoperable tools are now central to operational efficiency, as sponsors deploy solutions that connect data capture, wearable monitoring, and imaging systems within core trial infrastructure.
- Decentralized and hybrid trial models are expanding quickly, boosting demand for flexible remote monitoring and advanced biosample logistics while increasing the value of supply-chain resilience and last-mile fulfillment.
- Vendor relationships are evolving as service providers and CROs expand via technology acquisitions and licensing, enabling modular, rapidly deployable solutions that meet increasingly specialized sponsor needs.
- Patient-centric approaches, including real-world data collection and digital engagement, are redefining requirements for monitoring and biosample handling across therapeutic areas and trial phases.
- Organizations are prioritizing sourcing frameworks that address operational risks and regulatory variability, ensuring qualification of suppliers across geographies to maintain trial timelines and compliance.
Why This Report Matters
- Guides executives in framing decisions for development, procurement, and supply chain design in the evolving clinical trial landscape.
- Enables benchmarking of technology adoption, vendor specialization, and regional differentiation, supporting informed investment and sourcing strategy.
- Offers a clear lens on regulatory and operational complexities, supporting risk mitigation and timeline preservation as therapeutic and trial models advance.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2026-2032 |
| Estimated Market Value (USD) in 2026 | $5.46 Billion |
| Forecasted Market Value (USD) by 2032 | $9.78 Billion |
| Compound Annual Growth Rate | 10.0% |
| Regions Covered | Global |
Key Topics Covered
1. Preface
2. Research Methodology
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Clinical Trial Equipment & Ancillary Solutions Market, by Component
8.1. Ancillary Solutions
8.1.1. Central Lab Services
8.1.2. Clinical Trial Management Systems (CTMS)
8.1.3. Data Management & Analytics Services
8.1.4. Electronic Data Capture (EDC) Systems
8.1.5. Interactive Response Technology (IRT)
8.1.6. Patient Engagement Solutions
8.1.7. Supply Chain & Logistics Solutions
8.2. Equipments
8.2.1. Drug Dispensing/Packaging Devices
8.2.2. Imaging Equipment
8.2.3. Laboratory Instruments
8.2.4. Monitoring Device
9. Clinical Trial Equipment & Ancillary Solutions Market, by Phase
9.1. Phase I
9.2. Phase II
9.3. Phase III
9.4. Phase IV
10. Clinical Trial Equipment & Ancillary Solutions Market, by Therapeutic Area
10.1. Cardiology
10.2. Immunology
10.3. Infectious Diseases
10.4. Neurology
10.5. Oncology
11. Clinical Trial Equipment & Ancillary Solutions Market, by End-User
11.1. Academic/Research Institutions
11.2. Biotechnology Firms
11.3. Contract Research Organizations (CROs)
11.4. Medical Device Companies
11.5. Pharmaceutical Companies
12. Clinical Trial Equipment & Ancillary Solutions Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Clinical Trial Equipment & Ancillary Solutions Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Clinical Trial Equipment & Ancillary Solutions Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Clinical Trial Equipment & Ancillary Solutions Market
16. China Clinical Trial Equipment & Ancillary Solutions Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Almac Group Limited
17.6. Ancillare, LP
17.7. Avantor, Inc.
17.8. Axelerist
17.9. B. Braun SE
17.10. Bio-Rad Laboratories, Inc.
17.11. Charles River Laboratories International, Inc.
17.12. Dassault Systemes SE
17.13. Emsere B.V.
17.14. Eppendorf SE
17.15. Eurofins Scientific SE
17.16. Global Vision Technologies, Inc.
17.17. Hitachi, Ltd.
17.18. IQVIA Holdings Inc.
17.19. Lonza Group Ltd.
17.20. MedNet Solutions, Inc.
17.21. Myonex, Inc.
17.22. Oracle Corporation
17.23. Parexel International Corporation
17.24. Quanticate International Limited
17.25. Quipment SAS
17.26. Thermo Fisher Scientific, Inc.
17.27. United Parcel Service, Inc.
17.28. Veeva Systems Inc.
17.29. Yokogawa Electric Corporation
17.30. Zifo Technologies Private Limited
For more information about this report visit https://www.researchandmarkets.com/r/cfefo0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
